Year |
Citation |
Score |
2019 |
Espinoza S, Scarpato M, Damiani D, Managò F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31495777 DOI: 10.1016/j.ymthe.2019.08.005 |
0.36 |
|
2019 |
Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/j.bbi.2019.06.006 |
0.36 |
|
2018 |
Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, et al. Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 3560. PMID 30158661 DOI: 10.1038/s41467-018-06062-y |
0.48 |
|
2018 |
Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, et al. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 2265. PMID 29891954 DOI: 10.1038/s41467-018-04711-w |
0.48 |
|
2018 |
Cavaccini A, Gritti M, Giorgi A, Locarno A, Heck N, Migliarini S, Bertero A, Mereu M, Margiani G, Trusel M, Catelani T, Marotta R, De Luca MA, Caboche J, Gozzi A, et al. Serotonergic Signaling Controls Input-Specific Synaptic Plasticity at Striatal Circuits. Neuron. PMID 29706583 DOI: 10.1016/j.neuron.2018.04.008 |
0.32 |
|
2017 |
Giorgi A, Migliarini S, Galbusera A, Maddaloni G, Mereu M, Margiani G, Gritti M, Landi S, Trovato F, Bertozzi SM, Armirotti A, Ratto GM, De Luca MA, Tonini R, Gozzi A, et al. Brain-wide Mapping of Endogenous Serotonergic Transmission via Chemogenetic fMRI. Cell Reports. 21: 910-918. PMID 29069598 DOI: 10.1016/j.celrep.2017.09.087 |
0.32 |
|
2017 |
Ciampoli M, Contarini G, Mereu M, Papaleo F. Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task. Scientific Reports. 7: 9936. PMID 28855580 DOI: 10.1038/s41598-017-10112-8 |
0.36 |
|
2017 |
Pintori N, Loi B, Mereu M. Synthetic cannabinoids: the hidden side of Spice drugs. Behavioural Pharmacology. PMID 28692429 DOI: 10.1097/FBP.0000000000000323 |
0.36 |
|
2017 |
Huang H, Guadagna S, Mereu M, Ciampoli M, Pruzzo G, Ballard T, Papaleo F. A schizophrenia relevant 5-Choice Serial Reaction Time Task for mice assessing broad monitoring, distractibility and impulsivity. Psychopharmacology. PMID 28378204 DOI: 10.1007/s00213-017-4611-z |
0.36 |
|
2016 |
Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, et al. Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening. Pharmacology, Biochemistry, and Behavior. PMID 27569602 DOI: 10.1016/j.pbb.2016.08.007 |
0.56 |
|
2016 |
Managò F, Mereu M, Mastwal S, Mastrogiacomo R, Scheggia D, Emanuele M, De Luca MA, Weinberger DR, Wang KH, Papaleo F. Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. Cell Reports. PMID 27524619 DOI: 10.1016/j.celrep.2016.07.044 |
0.48 |
|
2016 |
Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Frontiers in Neuroscience. 10: 153. PMID 27147945 DOI: 10.3389/fnins.2016.00153 |
0.32 |
|
2015 |
Varcasia A, Brianti E, Tamponi C, Pipia AP, Cabras PA, Mereu M, Dantas-Torres F, Scala A, Otranto D. Simultaneous infection by four feline lungworm species and implications for the diagnosis. Parasitology Research. 114: 317-21. PMID 25367212 DOI: 10.1007/s00436-014-4207-z |
0.56 |
|
2015 |
Mereu M, Tronci V, Chun LE, Thomas AM, Green JL, Katz JL, Tanda G. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice. Addiction Biology. 20: 91-103. PMID 23910902 DOI: 10.1111/adb.12080 |
0.56 |
|
2014 |
Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biological Psychiatry. 76: 802-9. PMID 24853388 DOI: 10.1016/j.biopsych.2014.03.031 |
0.56 |
|
2013 |
Mereu M, Bonci A, Newman AH, Tanda G. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology. 229: 415-34. PMID 23934211 DOI: 10.1007/s00213-013-3232-4 |
0.56 |
|
2013 |
Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, Kopajtic TA, Newman AH, Katz JL. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change. Psychopharmacology. 229: 307-21. PMID 23612854 DOI: 10.1007/s00213-013-3109-6 |
0.56 |
|
2013 |
Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 605-15. PMID 23187725 DOI: 10.1038/npp.2012.224 |
0.56 |
|
2013 |
Enrico P, Sirca D, Mereu M, Peana AT, Mercante B, Diana M. Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat. Drug and Alcohol Dependence. 127: 8-14. PMID 22809896 DOI: 10.1016/j.drugalcdep.2012.06.006 |
0.56 |
|
2012 |
Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biological Psychiatry. 72: 405-13. PMID 22537794 DOI: 10.1016/j.biopsych.2012.03.022 |
0.56 |
|
2011 |
Sirca D, Enrico P, Mereu M, Peana AT, Diana M. L-cysteine prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Alcoholism, Clinical and Experimental Research. 35: 862-9. PMID 21303385 DOI: 10.1111/j.1530-0277.2010.01416.x |
0.56 |
|
2011 |
Garcés-RamÃrez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biological Psychiatry. 69: 208-17. PMID 20950794 DOI: 10.1016/j.biopsych.2010.07.026 |
0.56 |
|
2010 |
Peana AT, Muggironi G, Calvisi G, Enrico P, Mereu M, Nieddu M, Boatto G, Diana M. l-Cysteine reduces oral ethanol self-administration and reinstatement of ethanol-drinking behavior in rats. Pharmacology, Biochemistry, and Behavior. 94: 431-7. PMID 19879891 DOI: 10.1016/j.pbb.2009.10.005 |
0.56 |
|
2009 |
Enrico P, Sirca D, Mereu M, Peana AT, Lintas A, Golosio A, Diana M. Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Drug and Alcohol Dependence. 100: 265-71. PMID 19070441 DOI: 10.1016/j.drugalcdep.2008.10.010 |
0.56 |
|
2007 |
Enrico P, Sirca D, Mereu M. Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy. Progress in Brain Research. 166: 323-30. PMID 17956795 DOI: 10.1016/S0079-6123(07)66029-4 |
0.56 |
|
Show low-probability matches. |